Clinical pharmacology studies built for speed, quality and control
Run complex early phase studies with a 100-bed Phase I unit, cGMP compliant pharmacy, in-house clinical lab and purpose-built technology.
Discuss your clinical development program.
This form is for sponsor and CRO partnership inquiries. Share a few details about your upcoming study, and our team will follow up.
Looking to participate in a study? Visit our volunteer website.
Built differently for early phase delivery
Early phase studies depend on disciplined execution, clear ownership and reliable data from the start. We combine an experienced clinical pharmacology team, a purpose-built Phase I environment and integrated technology to support accurate, actionable and audit-ready study delivery.
Purpose-built facility
A 75,000 sq. ft. research complex with a 100-bed clinical pharmacology unit, private suites and infrastructure designed to support early phase study conduct.
Exceptional responsiveness
Direct access to experienced study teams supports clear communication and aligned decision-making from startup through closeout.
Unmatched flexibility & agility
Our clinical pharmacology team adapts quickly to study needs while protecting timelines, budgets and execution quality.
Team continuity
Consistent, early phase-focused teams preserve study knowledge, reduce handoff friction and provide stable ownership throughout the study lifecycle.
Technology & innovation
Integrated eSource, EDC, barcode scanning, equipment integration and real-time sponsor access support cleaner data, greater visibility and audit-ready documentation.
Sponsor confidence in early phase execution
The project managers, clinical monitors, investigators, entire clinical pharmacology unit team, medical monitor and data managers have years of experience with the management and conduct of early phase studies. I highly recommend DVCR.
Physician Scientist and Biotech Executive
cGMP pharmacy
Our on-site, 2,500 sq. ft. cGMP compliant pharmacy provides the infrastructure and experience needed to support complex clinical pharmacology studies within the Phase I unit.
Key capabilities include:
- 50+ years of combined early clinical development pharmacy experience
- Investigational product handling across multiple routes of administration
- Injectable formulations, including IV, IM and subcutaneous
- Nasal insufflation
- Powder-in-capsule and powder-in-solution
- Over-encapsulation
- USP 795 and USP 797 compliant preparation spaces
- ISO 8 anteroom and ISO 7 cleanroom environments
- Cold storage and controlled substance storage
- HEPA filtration and Class II Type A2 biosafety cabinets